Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €132.94 EUR
Change Today -0.422 / -0.32%
Volume 1.7M
BAYN On Other Exchanges
Symbol
Exchange
OTC US
Xetra
OTC US
BrsaItaliana
Xetra
Mexico
Continuous
As of 2:55 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yüksel Karaaslan

Member of Supervisory Board, Bayer AG
AgeTotal Calculated CompensationThis person is connected to 40 board members in 2 different organizations across 2 different industries.

See Board Relationships
46€125,000

Background*

Mr. Yüksel Karaaslan serves as Chairman of the Works Council of the Berlin site of Bayer and Vice Chairman of the Bayer Central Works Council. Mr. karaaslan has been Member of Supervisory Board of Bayer Pharma AG (Former Name, Bayer Schering Pharma AG) since November 29, 2006 and Bayer AG since April 27, 2012.

Corporate Headquarters*

Kaiser-Wilhelm-Allee 1
Leverkusen, North Rhine-Westphalia 51368

Germany

Phone: 49 214 301
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation€125,000
Total Calculated Compensation€125,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYN:GR €132.94 EUR -0.422

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Sanofi
€700.0K
Alan Jon Clark MA, D.LitteT. Phil.Chief Executive Officer, Executive Director, Chairman of Nomination Committee, Member of Executive Committee, Member of Disclosure Committee and Member of Corporate Accountability & Risk Assurance Committee
SABMiller plc
2.3M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.